UNI-EN 95:Current report 95 re insiders transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 95 | / | 2016 | |||||||
| Date of issue: | 2016-10-14 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 95 re insiders transactions | |||||||||||
| Official market - legal basis | |||||||||||
| art. 19. 3 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD (the “Company”) announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that the company ELPHARMA related to him, executed the following transactions related to shares of the Company: Date and time of settlement Operation Number of shares Unit price (BGN) 29.9.2016 Sale 2 000 2.8480 30.9.2016 Sale 2 371 2.9300 30.9.2016 Sale 2 629 2.9300 30.9.2016 Sale 1 000 2.9450 30.9.2016 Sale 204 2.9450 30.9.2016 Sale 1 500 2.9450 30.9.2016 Sale 296 2.9450 30.9.2016 Sale 2 000 2.9900 3.10.2016 Sale 10 3.0400 3.10.2016 Sale 990 3.0400 3.10.2016 Sale 1 030 3.0550 3.10.2016 Sale 970 3.0550 3.10.2016 Sale 1 000 3.0550 3.10.2016 Sale 1 893 3.0550 3.10.2016 Sale 3 000 2.9700 3.10.2016 Sale 150 2.9700 3.10.2016 Sale 3 400 2.9700 3.10.2016 Sale 1 450 2.9700 3.10.2016 Sale 1 450 2.9700 3.10.2016 Sale 1 550 2.9700 3.10.2016 Sale 3 000 2.9700 3.10.2016 Sale 270 2.9620 3.10.2016 Sale 341 2.9630 3.10.2016 Sale 341 2.9630 3.10.2016 Sale 341 2.9630 3.10.2016 Sale 341 2.9630 3.10.2016 Sale 295 2.9630 3.10.2016 Sale 71 2.9630 4.10.2016 Sale 2 000 2.9600 4.10.2016 Sale 3 400 2.9550 4.10.2016 Sale 240 2.9550 4.10.2016 Sale 306 2.9550 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 95 re insiders transactions.doc Current report 95 re insiders transactions.doc | Current report 95 re insiders transactions | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2016-10-14 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 6.5 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
